Clinical Trial Update: In Situ Injection of Anti-angiogenics in Patients With Brain Arteriovenous Malformations Not Eligible for Exclusion Treatment [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating in situ injection of anti-angiogenic agents for brain arteriovenous malformations; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Arteriovenous Malformations

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Brain Arteriovenous Malformations | Phase 1 | Status: NOT_YET_RECRUITING